Chronic Fatigue Therapy 17312-0170-14
Generic: Epinephrine, Gold, Chelidonium Majus, Echinacea, Ginkgo, Helleborus Niger, Phosphoric Acid, Scutellaria Lateriflora, Thuja Occidentalis
- Manufacturer
- Trp Company
- Dosage Form
- Tablet, Orally Disintegrating
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- August 20, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Chelidonium Majus | 6 [hp_X]/1 |
| Echinacea, Unspecified | 3 [hp_X]/1 |
| Epinephrine | 7 [hp_X]/1 |
| Ginkgo | 3 [hp_X]/1 |
| Gold | 8 [hp_X]/1 |
| Helleborus Niger Root | 6 [hp_X]/1 |
| Phosphoric Acid | 6 [hp_X]/1 |
| Scutellaria Lateriflora | 6 [hp_X]/1 |
| Thuja Occidentalis Leafy Twig | 6 [hp_X]/1 |
Drug Class
alpha-Adrenergic Agonist [EPC]beta-Adrenergic Agonist [EPC]Catecholamine [EPC]
Selected Package
17312-0170-14Selected1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE